Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centratama Telekomunikasi Indonesia Tbk. (CENT) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Centratama Telekomunikasi Indonesia Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Centratama Telekomunikasi Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Centratama Telekomunikasi Indonesia Tbk. trades at Rp74 (market cap 2.34T, 535.2K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 4.8× Centratama Telekomunikasi Indonesia Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 535.2K). Which is the better fit depends on your goals.

CENTTSPC
Market Cap
2.34T11.18T
Volume
535.2K613K
Lot
5.35K6.13K
Turnover
39.66M1.54B
Average Price
74.12,511.52
Value
39.66M1.54B
Indicative Equilibrium Price
742,520
Indicative Equilibrium Volume
52717

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CENT
View details
TSPC
View details

About Centratama Telekomunikasi Indonesia Tbk.

PT Centratama Telekomunikasi Indonesia Tbk formerly Centrin Online The corporate was established on February 11th 1987 in Bandung as PT. Centrindo Utama. Since the first establishment, corporate focus the business on the information technology. Start the operation in computer hardware sales such as supporting hardware and monitor which produced by PT. Central Rama Informatiko as a affiliated company. And start the internet service provider business on 1996.

Read more on CENT

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC